http://www.acc.org/Feed?clinicalTopicID=6b61a878-cc26-4614-bacb-c8aefa3cdede Clinical Topic Feed: Anticoagulation Management and ACS en /Latest-in-Cardiology/Articles/2026/03/04/14/11/eagles-eye-view-04mar2025 In this week’s View, Dr. Eagle looks at increased one-year mortality in younger patients undergoing transcatheter aortic valve replacement (TAVR). 1772636400000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/02/26/18/18/20-Year-Outcomes Twenty years after pulmonary vein isolation (PVI) during catheter ablation, stable sinus rhythm was maintained in a quarter of patients with symptomatic drug-refractory paroxysmal atrial fibrillation (PAF), including those taking antiarrhythmic drugs and those who had multiple ablation procedures, according to findings from a study published Feb. 17 in JACC: Clinical Electrophysiology. 1772131380000 Articles and Stories /Latest-in-Cardiology/Articles/2025/12/01/01/Journal-Wrap The hottest research from various peer-reviewed journals – handpicked weekly by the ACC. 1764594240000 Articles and Stories /Latest-in-Cardiology/Articles/2025/11/12/14/25/eagles-eye-view-12nov2025 In this week’s View, Dr. Eagle highlights several important studies presented at the recent American Heart Association Scientific Sessions. 1762957560000 Articles and Stories /Latest-in-Cardiology/Clinical-Trials/2025/12/17/18/59/CELEBRATE The CELEBRATE trial demonstrated that a single injection of zalunfiban administered at first medical contact in patients with suspected STEMI significantly improved patency of the infarct-related artery at index angiography and reduced the likelihood of a composite of all-cause death, stroke, recurrent myocardial infarction (MI), stent thrombosis, heart failure, and larger MI at 30 days. 1762801200000 Articles and Stories /Latest-in-Cardiology/Articles/2025/11/03/16/19/mon-915am-tuxedo-aha-2025 In patients with diabetes and multivessel coronary artery disease undergoing PCI, a ticagrelor-based dual antiplatelet therapy (DAPT) regimen did not offer the same level of benefit at preventing heart attack, stroke, bleeding complications or death as a prasugrel-based DAPT regimen... 1762784100000 Articles and Stories /Latest-in-Cardiology/Articles/2025/11/03/16/19/mon-9am-celebrate-aha-2025 A single subcutaneous injection of zalunfiban administered on first medical contact with patients with suspected STEMI was associated with improved patency of the infarct-related artery at index angiography and a significantly lower chance of all-cause death, stroke, recurrent myocardial infarction (MI)... 1762783200000 Articles and Stories /Latest-in-Cardiology/Articles/2025/11/03/16/19/sat-315pm-afib-aha-2025 Four major studies presented at AHA 2025 are reshaping strategies for managing atrial fibrillation (AFib) in complex clinical scenarios. OCEAN addresses whether ongoing anticoagulation is necessary after successful catheter ablation, offering fresh insights into stroke prevention and bleeding risk. ADAPT AF-DES and OPTIMA-AF explore optimal antithrombotic approaches after PCI, while CLOSURE-AF evaluates left atrial appendage closure (LAAC) vs. medical therapy in high-risk patients. 1762633980000 Articles and Stories /Latest-in-Cardiology/Articles/2025/11/05/14/21/eagles-eye-view-05nov2025 In this week’s View, Dr. Eagle highlights several trials recently presented at the TCT Conference in San Francisco. 1762352580000 Articles and Stories https://www.jacc.org/doi/10.1016/j.jacc.2024.11.009 1740682800000 Guidelines